BERNARD-SOULIER SYNDROME

 

BERNARD-SOULIER SYNDROME

 

DEFINITION:

A congenital qualitative platelet disorder characterized by an abnormality in platelet adhesion resulting in a congenital thrombocytopenia and a bleeding tendency.

EPIDEMIOLOGY:

  • incidence: rare
  • age of onset:
    • ?
  • risk factors:
    • familial - autosomal recessive
      • chrom.#: 17pter-p12
      • gene: glycoprotein Ib (alpha subunit)
    • M = F

PATHOGENESIS:

1. Background

  • Ib, IX, and V are glycoproteins each synthesized from different genes
  • the platelet glycoprotein Ib-IX-V complex represents a membrane receptor that performs an essential role in the thrombogenic function of platelets by acting as the binding site for von Willebrand factor (vWf)
  • furthermore, this complex is attached to the platelet cytoskeleton by an actin-binding protein and is thus involved in maintaining the disk shape of the platelet
  • Bernard-Soulier Syndrome was first described in 1948 by Bernard and Soulier and platelets isolated from patients have been found to lack glycoproteins Ib, IX, and V

2. Genetic Defect

  • genetic defect -> abnormal synthesis of glycoprotein Ib
    • -> platelets cannot bind vWf -> platelets cannot adhere to the subendothelium at the site of injured blood vessels resulting in an increased bleeding time
    • -> disruption of the structural integrity of the platelet -> giant dysfunctional platelets
  • a point mutation in the gene coding for the alpha subunit of glycoprotein Ib results in the Bernard-Soulier phenotype (J. Clinical Invest. 92(3): 1213 [1993])
  • it will probably turn out that defects in the genes coding for the Ib, IX, or V glycoproteins can all result in the Bernard-Soulier phenotype

CLINICAL FEATURES:

1. Hematological Manifestations

1. Bleeding

  • 1. Skin
    • easy bruising, petechiae, purpura
  • 2. Mucous Membranes
    • recurrent epistaxis, gingival bleeding
    • menorrhagia
  • 3. Others
    • excessive bleeding at the time of injury or surgery
  • INVESTIGATIONS:

    1. Serum

    • thrombocytopenia
    • prolonged bleeding time
    • low glycoprotein Ib, IX, and V levels
    • platelets unresponsive to ristocetin in vitro

    2. Peripheral Blood Smear

    • giant bizarre platelets (mean diameter = 5-6 microns)

    MANAGEMENT:

    1. Supportive

  • 1. Platelet Transfusions
    • avoid as alloantibodies against glycoprotein Ib form which results in the rapid destruction of transfused normal platelets in the future
    • 2. DDAVP
      • may transiently improve hemostasis
  • 2. Bone Marrow Transplantation

    • experimental

     

     

     

    Pediatric Database - BERNARD-SOULIER SYNDROME

    Pediatric Organization - Pedbase [at] Gmail.com